BIOPHARMACOPAE DESIGN INTERNAT has a total of 17 patent applications. Its first patent ever was published in 2002. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are TAS SINAN, ZOUBOULIS CHRISTOS C and LEGACY HEALTHCARE HOLDING LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Canada | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | United States | 3 | |
#5 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Foods and drinks | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Specific use of cosmetics | |
#4 | Foods | |
#5 | Microorganisms | |
#6 | Measuring microorganism processes | |
#7 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Cyr Benoit | 14 |
#2 | Guay Johane | 4 |
#3 | Gendron Nathalie | 4 |
#4 | Page Brigitte | 4 |
#5 | Lavallee Bernard | 3 |
#6 | Duret Philippe | 3 |
#7 | Behr Stephen | 3 |
Publication | Filing date | Title |
---|---|---|
WO2009121168A1 | Extracts from plants of the tsuga genus and uses thereof in the treatment of inflammation, irritation and/or infection | |
US2009004302A1 | Methods and Therapeutic Compositions Comprising Plant Extracts for the Treatment of Cancer | |
WO2006053415A1 | Plant extract having matrix metalloprotease inhibiting activity and dermatological uses thereof | |
EP1539204A1 | Plant extracts for treatment of angiogenesis and metastasis | |
CA2437259A1 | Plant extracts and compositions comprising extracellular protease inhibitors | |
EP1370272A1 | Inhibitors of extracellular proteases |